Therapeutic Gene
US6541219B1 · kind B1 · utility
3Cited by
2References
11Claims
0Family size
Inventors
Key dates
| Filing date | Jun 21, 1999 |
| Grant date | Apr 1, 2003 |
| Priority date | — |
| Expiry date | Jun 21, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/027
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Polynucleotide sequences and vectors containing them, for use in gene therapy, the polynucleotide sequences comprising two or more therapeutic genes operably linked to a promoter and encoding a fusion protein product of the therapeutic genes. The fusion protein may be for example a tyrosine hydroxylase (TH)-DOPA decarboxylase (DD) fusion in either TH-DD or DD-TH order, useful for treating Parkinson's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.